#Mass Spectrometry Market Growth

[health-views-updates]

Mass Spectrometry Market Insights: Future Trends and Growth

Mass Spectrometry Market Outlook, Scope & Overview:

Industry reports indicate that the global mass spectrometry market was valued at USD 5,195.45 million in 2022 and is projected to reach USD 9,723.78 million by 2030, growing at a CAGR of 8.15% over the forecast period 2023-2030.

Technological Advancements to Drive Growth of Global Mass Spectrometry Market

The adoption of advanced mass spectrometry technologies will continue to influence global market revenues. Laboratories and research institutions are increasingly utilizing mass spectrometry for its high accuracy and sensitivity in detecting and quantifying molecules in complex mixtures.

As a product segment, hybrid mass spectrometry systems currently hold a significant share of the global mass spectrometry market. This segment is anticipated to grow at a year-over-year rate of 8.15% in 2023 over 2022 and reach USD 9,723.78 million in revenues by 2030. The increasing demand for precise analytical techniques in pharmaceuticals, biotechnology, and environmental testing is expected to drive market growth.

Get a Free Sample Report: https://www.snsinsider.com/sample-request/3835 

Mass Spectrometry Solutions – Market Dynamics

Drivers:

Mass spectrometry solutions are witnessing significant growth in the global market due to their ability to provide highly accurate and sensitive analysis of complex samples. The increasing adoption of mass spectrometry in proteomics, metabolomics, and drug discovery, coupled with advancements in mass spectrometry technology, are key factors driving the adoption of these solutions worldwide. Additionally, the rising demand for personalized medicine and the growing focus on biomarker discovery are further propelling market growth.

Restraints:

Despite the growth potential, challenges such as the high cost of mass spectrometry equipment, the need for specialized training and expertise to operate the instruments, and concerns about data accuracy and reproducibility are hindering the widespread adoption of mass spectrometry solutions. Moreover, the complexity of integrating mass spectrometry systems with existing laboratory workflows poses additional challenges to market expansion.

Mass Spectrometry Solutions – Market Outlook

The proven benefits of mass spectrometry solutions in providing precise and reliable analytical results, improving research outcomes, and enhancing drug development processes have contributed to the market's growth. Mass spectrometry solutions are expected to witness increased adoption across major markets, including North America, Europe, and Asia Pacific, driven by advancements in technology and the growing focus on high-throughput and high-resolution analytical techniques.

Global Mass Spectrometry Market

The rise in demand for mass spectrometry solutions in developed and emerging markets is expected to drive market growth over the forecast period. North America currently holds a significant market share in the global mass spectrometry market, with the US being a key contributor to market revenues. Europe and Asia Pacific regions are also experiencing rapid adoption of mass spectrometry solutions, supported by increasing investments in research and development and favorable regulatory frameworks.

Key Players in the Mass Spectrometry Solutions Market

Leading companies in the mass spectrometry solutions market include Agilent Technologies, Thermo Fisher Scientific, Waters Corporation, and Bruker Corporation. These companies are at the forefront of developing and commercializing advanced mass spectrometry platforms for various applications, including pharmaceuticals, biotechnology, environmental testing, and food safety.

In conclusion, the global mass spectrometry market is poised for substantial growth over the forecast period, driven by technological advancements, increasing research activities, and the expanding adoption of mass spectrometry solutions in diverse analytical applications.

Other Trending Reports

Online Pharmacy Industry Growth

Toxoid Vaccine Industry Growth

Healthcare EDI Industry Growth

Dental Practice Management Software Industry Growth

[medicaldevicesindustrynews]

The Perfect Guide to Mass Spectrometry

The Perfect Guide to Mass Spectrometry

Ionizing a sample and measuring the mass-to-charge ratios of the resultant ions are both possible using mass spectrometry (MS). The number of MS applications grows as a result of the mass spectrometer’s integration with computer technology and software. MS has been able to infiltrate a wide range of study domains, including biochemistry, chemistry, medicine, pharmacy, and many other relevant…

[industrynewsupdates]

Global Expansion of Newborn Screening Market: What You Need to Know

The global newborn screening market was valued at USD 789.35 million in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 7.54% from 2023 to 2030. This growth is primarily driven by several factors, including an increasing neonatal population, a rising incidence of congenital diseases in newborns, heightened consumer awareness, and supportive initiatives from various governments that are implementing programs and legislations to promote newborn screening. Additionally, advancements in screening technologies are expected to further enhance market growth.

The growing prevalence of congenital diseases among newborns is anticipated to positively impact the newborn screening market. According to data released by the World Health Organization (WHO) in February 2023, approximately 240,000 newborns worldwide die within the first 28 days of life each year due to congenital conditions. These disorders are also linked to around 170,000 child deaths annually among those aged between one month and five years. Furthermore, research from Indian Pediatrics indicates that congenital hypothyroidism occurs in 2.1 out of every 1,000 infants in India, with the prevalence of inborn metabolic disorders ranging from 2% to 7.8%. The significant occurrence of congenital diseases in newborns is likely to drive the demand for testing, thereby accelerating market growth by 2030.

Gather more insights about the market drivers, restrains and growth of the Newborn Screening Market

Technology Insights

In 2022, the tandem mass spectrometry segment emerged as the dominant force in the newborn screening market, capturing 24.5% of the overall revenue share. This leadership position can be attributed to several key factors, including its cost-effectiveness, broader applicability across various testing scenarios, and continuous technological advancements. Tandem mass spectrometry (MS/MS) is particularly valued for its ability to efficiently diagnose a wide range of medical conditions in a single testing procedure, making it an invaluable tool in newborn screening.

The efficiency of tandem mass spectrometry allows healthcare professionals to conduct comprehensive screenings that can identify multiple disorders simultaneously, thereby facilitating timely interventions. As the healthcare landscape evolves, the demand for rapid and accurate diagnostic tools has surged. This trend is likely to propel the tandem mass spectrometry segment to experience substantial growth, with a significant compound annual growth rate (CAGR) projected over the coming years. The innovative advancements being made by key market players are also expected to contribute to this growth. For example, in April 2023, Waters Corporation unveiled its new Xevo TQ Absolute IVD Mass Spectrometer, designed specifically for clinical applications. This product exemplifies the continuous push for technological enhancements that not only improve diagnostic accuracy but also streamline laboratory workflows.

In addition to tandem mass spectrometry, the electrophoresis segment is anticipated to see notable demand, projecting an impressive CAGR of 8.09% throughout the forecast period. The increasing emphasis on early detection techniques in healthcare is a primary driver behind this growth. Early diagnosis is crucial in managing congenital diseases effectively, as it allows for timely treatment and better health outcomes for newborns. Consequently, as healthcare providers and institutions prioritize early intervention strategies, the demand for electrophoresis is expected to rise correspondingly.

The growth of the electrophoresis segment is further supported by a surge in collaborations among various market players. Such partnerships often lead to innovative solutions that enhance product offerings and broaden market reach. For instance, in October 2022, CMP Scientific Corp. entered into a co-marketing agreement with Agilent to promote its advanced electrophoresis system. This collaboration not only aims to improve the technological capabilities of electrophoresis solutions but also focuses on expanding accessibility to these crucial diagnostic tools in newborn screening programs.

Moreover, the increasing focus on research and development in the field of newborn screening technologies is set to further enhance the capabilities of both tandem mass spectrometry and electrophoresis. As new methodologies and products are introduced, healthcare providers will be better equipped to address the complexities associated with congenital diseases. The integration of advanced technologies is expected to foster innovation, leading to more efficient, reliable, and cost-effective solutions for newborn screening.

Order a free sample PDF of the Newborn Screening Market Intelligence Study, published by Grand View Research.

[research2168]

Unveil Growth in the Global Certified Reference Materials Market

Market Overview

The worldwide Certified Reference Materials (CRMs) market is predicted to grow at a CAGR of 6.8% from 2024 to 2031, driven by increasing quality control and assurance needs across sectors. Stringent regulatory regulations, notably in the pharmaceutical and environmental sectors, are driving the implementation of CRM. Furthermore, increased focus on food safety and the growth of research facilities are helping to expand the industry.

Market Trends

The demand for matrix-matched CRMs is gaining traction in the industry, as these materials provide more accurate and reliable results for sample analysis of complex matrices. Matrix-matched CRMs simulate real sample sets better and enable more precise calibration and validation of analytical methods. Manufacturers are investing in developing matrix-compliant CRMs to meet the specific needs of various sectors and analytical approaches, driving market growth as labs seek to improve the accuracy of their analytical results.

Market Segmentation

Organic Certified Reference Materials (CRMs) hold the largest market share, driven by increasing demand in pharmaceutical, food, and environmental testing applications. These CRMs are essential for analyzing organic solids, pesticides, chemicals, and contaminants in food. The focus on food safety, pharmaceutical manufacturing, and environmental monitoring has significantly increased the demand for organic CRMs. Advances in analytical techniques such as chromatography and mass spectrometry have further expanded their applications, contributing to their market leadership.

Know More: Download Sample

[trendingrepots]

Molecular Diagnostics Market - Forecast, 2024 - 2030

Molecular Diagnostics Market Overview

The Molecular Diagnostics Market Size is forecast to reach $ 3240.4 Million by 2030, at a CAGR of 8.60% during forecast period 2024-2030. Molecular diagnostics can be demarcated as a group of techniques proficient in identifying specific genetic disparities in patients by using diverse technologies such as polymerase chain reaction, single nucleotide polymorphisms, electrophoresis, isothermal nucleic acid amplification technology, mass spectrometry to scrutinize biomarkers in the genome. Molecular diagnostics allows doctors to select an unsurpassed form of therapy by supporting the detection of maladies and possible risks. Moreover, it helps medical professionals to chart individualized or customer-specific plans. Therefore, accurate prescription and treatment duration help patients circumvent lengthy recapitulations of pointless drugs being used on patients recurrently with hostile effects. Besides cancer monitoring, molecular diagnostic can be used to manage infections like methicillin-resistant staphylococcus. Nevertheless, rising incidences of infections and cancer, augmenting health attentiveness among people, hiking demand for personalized medicines, and enlarging research and developmental activities are the factors set to drive the growth of the Molecular Diagnostics Industry for the period 2024-2030.

 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞

Report Coverage

The report: “Molecular Diagnostics Market Forecast (2024-2030)” by Industry ARC covers an in-depth analysis of the following segments of the Molecular Diagnostics Market.

By Product: Reagents, Instrument, and other devices.

By Application: Leukocyte Antigen Typing, Oncology, Blood screening, Transferrable ailments, and Others.

By Technology: TMA, In Situ Hybridization, PCR, DNA sequencing, INAAT, and Others.

By End User: Hospitals, Laboratories, CROs, and Other medical facilities.

By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest of World (the Middle East and Africa).

Key Takeaways

Geographically, North America’s Molecular Diagnostics Market accounted for the highest revenue share in 2021. The growth is owing to full-fledged healthcare infrastructure, the presence of top-notch pharmacy and biopharmaceutical companies, and the high disposable income of people. Furthermore, Asia-Pacific is poised to offer lucrative growth opportunities over the forecast period owing to rising disposable incomes and the higher class of the geriatric population, among many other reasons.

Intensifying cancer cases are said to be the preeminent driver driving the growth of the Molecular Diagnostics Market. The exorbitant cost of the associated treatments and instruments is said to reduce the market growth.

Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Molecular Diagnostics Market report.

[communicationblogs]

Argon Gas Market — Forecast(2024–2030)

Argon Gas Market Overview

Argon Gas Market is forecast to reach $597.5 million by 2030, after growing at a CAGR of 5.2% during 2024–2030. Cryogenic fractional distillation and gas chromatography are the most common methods for producing argon gas. Rising consumption and demand from the growing metal manufacturing industry for argon gas, coupled with increasing industrialization, especially in emerging economies are the major factors expected to drive the growth of the Argon Gas Market. Due to the rising demand for argon gas in numerous application segments such as electronics, stainless steel, and fabricated metalworking, the Argon Gas Market is expected to grow globally. Furthermore, technological innovation such as the increasing use of electrospray ionization mass spectrometry in the healthcare industry is anticipated to create new opportunities for the growth of the global argon gas industry in the forecast era. Argon gas finds extensive use in electronics manufacturing, particularly in the production of semiconductors and other electronic components. The trend is driven by the need for a controlled atmosphere during processes like sputtering and plasma etching. 

Request Sample

The semiconductor industry’s continuous growth is propelling the demand for high-purity Argon, contributing to market expansion. The healthcare sector is increasingly adopting Argon gas for medical applications, including cryopreservation and laser surgeries. Argon’s inert properties make it suitable for preserving biological samples, while its use in medical lasers ensures precision and minimal tissue damage. With advancements in medical technology, the healthcare industry is becoming a significant consumer of Argon gas, driving market growth.

Impact of Covid-19

The consequences of the pandemic are altering Argon Gas Markets, as some manufacturers are either shutting down or reducing their supply due to a lack of demand from the downstream industry. Thus, this has led to a decline in the market growth for argon gas over the year 2020–21.

Argon Gas Market Report Coverage

The: “Argon Gas Market Report — Forecast (2024–2030)”, by IndustryARC, covers an in-depth analysis of the following segments of the Argon Gas Market.

By Grade: Food Grade, Industrial Grade, Scientific Grade, and Others

By Mixture: Argon-carbon dioxide, Argon-oxygen, Argon-nitrogen, Argon-hydrogen, and Others

By Function: Insulation, Illumination, and Cooling

By Application: Manufacturing & Fabrication, Lighting, 3-D printing, Lasers, Gas dischargetubes, Cinematography, Refrigeration, Windows, Tire

By End-Use Industry: Chemical Industry, Healthcare Industry, Transportation Industry, Food & Beverage Industry, Electrical & Electronics Industry, and Others

By Geography: North America (U.S, Canada, and Mexico), Europe (U.K., Germany, France, Italy, Netherlands, Spain, Russia, Belgium, and Rest of Europe), APAC (China, Japan, India, South Korea, Australia, Taiwan, Indonesia, Malaysia, and Rest of Asia Pacific), South America (Brazil, Argentina, Colombia, Chile, and Rest of South America), and RoW (Middle East and Africa)

Inquiry Before Buying

Key Takeaways

● The Asia Pacific region dominated the argon gas market due to the rapidly growing fabrication industries and the rising demand for argon gas from the food & beverage and healthcare sectors.

● Increasing use of argon gas owing to its greater thermal protection properties than air, for filling the dry suits used for scuba diving is anticipated to increase the demand for the argon gas market in the forecast period.

● Since Argon gas provides the inert atmosphere needed for rapid material cooling and heating, it is used in the electronics industry for the manufacture of semiconductors, flat panels, solar PV cells and microelectronic devices.

● Rising cause of inert gas asphyxiation among the workers by the consumption of argon gas in the absence of oxygen is anticipated to decline the growth of the market.

Argon Gas Market Segment Analysis — By Grade

Industrial grade held the largest share in the argon gas market in 2023. In MIG and TIG welding methods and plasma cutting applications due to its high density and absolute inertness, industrial-grade argon gas is widely used as a welding gas. Industrial-grade argon gas is supplied in gas bottles and cylinders of various sizes to suit consumer needs. Industrial-grade argon gas has many different applications in many industries. The most common application is either in pure form or as part of different mixtures, as a shielding gas for arc welding. Industrial-grade argon gas is one of the major gases for incandescent (filament) lamps, phosphorescent tubes, and thyratron radio tubes used in filling mixtures. Thus, with the rising demand for industrial-grade argon gas, the overall market is anticipated to rise in the forecast period.

Argon Gas Market Segment Analysis — By Mixture

Argon-carbon dioxide mixture is widely used in the argon gas market. Argon-carbon dioxide is a colorless, odorless, and non-flammable gas mixture. Argon mixtures with carbon dioxide are universal and are ideal for low-treated and stainless steel welding. One of the key composite components of safe welding mixtures is argon. Protective gas protects the electrode, metal, and hot metal near the welding seam from the ambient air as well as enhances the welding process and increases the welding characteristics. Argon-carbon dioxide blends can be used to incorporate a large spectrum of material thicknesses with a number of metal transition modes. With the rising use of argon-carbon dioxide mixture due to its unique properties, the market for argon gas is estimated to rise over the projected period.

Argon Gas Market Segment Analysis — By Function

Insulation function is highly preferred in the argon gas market. Argon serves as a barrier to prevent the indoor heat from escaping, like most insulating materials. But unlike most gases, the higher density of argon has greater thermal efficiency. This slow-moving gas, keeping heat loss to a minimum, allows less convection. To improve the energy consumption and general performance of thermal windows, argon gas is used. Insulated windows that are filled with argon gas are less likely to produce condensation. This is particularly true in areas of high humidity, such as the kitchen and the bathroom. Although good energy conservation could be demonstrated by fogging on the exterior surface of the glass, excessive humidity could result in water damage. With argon, to prevent it from sweating, the middle and the edges of the window glass will remain above the dew mark.

Argon Gas Market Segment Analysis — By Application

Manufacturing & Fabrication sector held the largest share in the argon gas market in 2023 and is projected to grow at a CAGR of 4.7% during the forecast period 2024–2030. During arc welding, it is often used as a shielding gas, because it shields the metal that is being worked on from oxygen. TIG, which stands for ‘tungsten inert gas’, utilizes both pure argon and argon mixtures. Argon decreases the chromium losses in the manufacture of steel in a converter, ensuring the desired carbon content can be reached at a lower and lower temperature. In aluminum processing, argon is often used to extract and degasify hydrogen. Also, cryogenic fractional distillation is used for producing argon gas of high purity, which is further used for the manufacturing and fabrication of semiconductor devices. Therefore, the rising demand for argon gas from the manufacturing and fabrication sector will drive the market demand for argon gas to grow in the forecast period.

Buy Now

Argon Gas Market Segment Analysis — By End-Use Industry

Automotive industry held the largest share of the argon gas market in 2023. Argon, due to its inert properties, is used in a wide variety of applications to help improve quality as well as maximize performance and yield in the manufacture of automotive parts. Owing to its alluring properties such as reduction or elimination of surface oxidation, improvement in part quality, decreasing scrap, and increasing efficiency and yields, it is used in a wide range of applications across automotive component manufacturing such as for welding, thermal, and plasma spraying, 3D printing, quenching, and others. Also, the most exotic use of argon is in the tires of luxury vehicles. Not only does the gas shield the tires from an oxygen attack, but it also provides less tire noise while the vehicle is moving at speed. With the rising automotive industry, the application of argon gas in the production of automotive components will also increase. According to the Association of Automobile Manufacturers (CAAM), China’s auto exports reached a record high of 4.91 million vehicles in 2023, up 57.9 percent year over year, as the nation’s automakers increased their global footprint. Thus, the rising demand for argon gas from the automotive industry is further estimated to raise the market growth.

Argon Gas Market Segment Analysis — Geography

For More Details on This Report — Request for Sample

Argon Gas Market Drivers

Increasing Price of Helium is Driving the Demand for Argon as an Alternative for Various Applications

Helium is replaced by argon in various sectors. Due to the high cost relative to argon, which has low cost and also has large applications, rising helium prices are expected to propel argon demand in many regions. Argon is used instead of helium because of the rising demand in separate application categories, such as stainless steel, electronics, and industrial metalworking sectors. According to the Oil Prices News Article in 2023, Helium prices skyrocketed when expectations of an abundant supply were not met; depending on purity and grade, they can sell for $500 Mcf to $1,000/Mcf. Prices are still ambiguous and change from transaction to transaction. Argon may be replaced by helium in the welding process. Also, helium is commonly used as a shielding gas for non-ferrous welding. Instead of helium, argon may be used and is favored by some metal forms. Owing to the above factors, an increase in demand for argon as an alternative to helium will drive the market for argon gas in the forecast period.

Rising Demand for Argon Gas in the Healthcare Industry

Cryogenic fractional distillation is used for the production of large quantities of purified argon in the healthcare industry. Argon is a noble gas component that has shown valuable narcotic and defensive capability in the medical sector. In order to selectively kill small areas of diseased or unhealthy tissue, especially on the skin, Argon is used to conduct accurate cryosurgery, which requires intense cold. Very cold argon is generated by controlled expansion of argon gas at the site and is driven using a cryoneedle to the treatment stage. This gives the device greater control than older liquid nitrogen techniques. A similar technique, cryoablation, is used to treat heart arrhythmia by destroying cells that interfere with the normal distribution of electrical impulses. As an important technique in clinical laboratories, electrospray ionization mass spectrometry (ESI-MS) has arisen. The increasing growth of argon in healthcare industries is expected to influence major trends in the global argon gas market in the coming years.

Argon Gas Market Challenges

Health Effects of Argon Gas Acts as a Constraint Towards the Growth of the Market

Argon gas can be absorbed into the body through inhalation. This liquid evaporates very rapidly with the lack of containment, creating air supersaturation and a significant risk of suffocation while in confined areas. Argon gas has been categorized as simple inert gas asphyxiation. Excessive inhalation can lead to dizziness, nausea, vomiting, loss of consciousness, and death. Death can result from mistakes that prevent self-rescue in judgment, misunderstanding, or lack of consciousness. Unconsciousness and death can occur in seconds without warning at low oxygen concentrations. Also, contact with argon gas can irritate and burn the skin and eyes. Very high levels of argon can decrease the amount of oxygen in the air and cause suffocation with symptoms of headache, rapid breathing, and loss of coordination and judgment. Hence, various harmful effects of argon gas on humans will further create hurdles for the argon gas market in the forecast period.

Market Landscape

● Technology launches, acquisitions and R&D activities are key strategies adopted by players in the argon gas market. Major players in the argon gas market are Taiyo Nippon Sanso Corporation, The Linde Group, Iwatani Corporation, Messer Group GmbH, Air Liquid S.A., SABIC, BASF SE, Air Products, and Space Cryogases Private Limited. and Matheson Tri-Gas Inc. among others.

Acquisitions/Technology Launches

• In October 2023, Inox Air Products intends to invest between Rs 300 and Rs 500 crore to build a supply network and purifying facilities for gases used by Indian semiconductor production facilities. Inox Air Products has started making investments in the purification of raw gases, such as oxygen, nitrogen, argon, helium, nitrous oxide, methane, silane, and ammonia, that are currently available in India. We’ll transform these gases into ultra-high purity.

[healthcaremarketanalysis]

RNA Analysis Industry worth $9.9 billion by 2028, with a CAGR of 13.4%

The global RNA analysis market growth forecasted to transform from USD 5.3 billion in 2023 to USD 9.9 billion by 2028, driven by a CAGR of 13.4%. Various elements such as increasing R&D activities, increasing government funding for drug discovery research, and growing pharmaceutical & biological industries are the major growth factors for this market. Many peptide-based research projects are also being fostered by increasing collaborative partnerships among various companies that are driving market growth.

Download an Illustrative overview:

Browse in-depth TOC on "RNA Analysis Market"

178 - Tables

46 - Figures

263 - Pages

The reagents/consumables segment accounted for the largest share of the product & service segment in the RNA analysis market in 2022.

Based on product & service, the RNA analysis market is segmented into reagents/consumables, instruments, software, and services. In 2022, the reagents/consumables segment accounted for the largest share of the RNA analysis market. The large share of this segment is fueled by the increasing demand for omics-based therapeutics, expanding research and development activities, and the availability of various RNA analysis reagents in the market.

The PCR segment accounted for the largest share of the technology segment in the RNA analysis market in 2022.

Based on technology, the RNA analysis market is segmented into PCR, sequencing, microarrays, and RNA interference. The PCR segment accounted for the largest share in the RNA analysis market in 2022. PCR is associated with several advantages, such as ease of operation, and short production cycles. These advantages support the growth of the PCR in the RNA analysis segment.

Asia Pacific is likely to grow at the highest growth rate during the forecast period.

Based on the region The global RNA analysis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest regional segment. The Asia Pacific region is estimated to grow at the highest CAGR in the RNA analysis market during the forecast period. The growth of the pharmaceuticals market in the region is primarily driven by the increasing prevalence of chronic diseases, the rising disposable incomes, the growing focus on personalized medicine, and the increasing government support for genomics and proteomics.

Request Sample Pages:

RNA Analysis Market Dynamics:

Drivers:

Growing demand for personalized medicine

Restraints:

High capital investments

Opportunities:

Opportunities in Emerging Countries

Challenges:

Data management in transcriptomics research

Key Market Players:

The prominent players operating in the RNA analysis market are Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), and Eurofins Scientific (Luxembourg).

Recent Developments:

In October 2022, Agilent Technologies and CMP Scientific Corp. entered into a co-marketing agreement to provide an integrated capillary electrophoresis-mass spectrometry (CE-MS) solution for the life science and pharmaceutical industries.

In March 2022, Eurofins acquired Beacon Discovery, a drug discovery-based CRO. Beacon supported the fully integrated drug discovery programs from target validation to pre-clinical candidates.

In January 2021, Thermo Fisher acquired Phitonex to provide greater flow cytometry and imaging multiplexing capabilities for protein and cell analysis research needs. Phitonex's product offerings are also an expansion of the company's existing protein and cell analysis portfolio.

Get 10% Free Customization on this Report:

RNA Analysis Market Advantages:

Unraveling Gene Expression: RNA analysis allows researchers to study the dynamic gene expression patterns in cells and tissues, providing valuable insights into how genes are regulated and how they respond to different stimuli, disease conditions, or treatments.

Disease Understanding: By analyzing RNA profiles, scientists can gain a deeper understanding of the molecular basis of various diseases, including cancer, neurological disorders, and infectious diseases. This knowledge can lead to the identification of biomarkers and potential therapeutic targets.

Personalized Medicine: RNA analysis has the potential to enable personalized medicine approaches. By profiling an individual's RNA, clinicians can tailor treatments to the patient's specific genetic makeup and disease characteristics, increasing treatment efficacy and minimizing adverse effects.

Advancements in Therapeutics: RNA analysis plays a crucial role in the development of novel RNA-based therapeutics, such as RNA interference (RNAi) and mRNA vaccines. These groundbreaking treatments have the potential to target specific genes and revolutionize disease management.

Diagnostic Applications: RNA analysis offers a wide range of diagnostic applications. From detecting infectious agents to identifying specific genetic mutations associated with diseases, RNA-based diagnostic tests can provide faster, more accurate results than traditional methods.

Biotechnology and Drug Development: In the biotechnology and pharmaceutical industries, RNA analysis is utilized to assess the safety and efficacy of potential drugs. It helps identify potential drug targets and provides valuable information during preclinical and clinical trials.

Agricultural Advancements: RNA analysis is also applied in agriculture to improve crop yields, develop disease-resistant varieties, and enhance the nutritional content of food.

Non-Invasive Testing: In certain cases, RNA analysis can be performed on non-invasive samples such as blood, urine, or saliva, reducing the need for invasive procedures and making it easier to monitor patients over time.

Technological Advancements: The RNA analysis market is continuously evolving with advancements in sequencing technologies, bioinformatics, and automation. These innovations have led to increased throughput, reduced costs, and improved accuracy in data analysis.

Research Tools: The availability of diverse RNA analysis tools and kits allows researchers to perform experiments efficiently and cost-effectively, fostering a broader adoption of RNA-focused studies across academic and commercial laboratories.

Overall, the growing advantages of RNA analysis have positioned it as a pivotal component in advancing our understanding of biology, driving medical breakthroughs, and shaping the future of personalized medicine and precision healthcare.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets Inc.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA : 1-888-600-6441

UK +44-800-368-9399

Email: sales@marketsandmarkets.com

Visit Our Website: https://www.marketsandmarkets.com/

[123567-9qaaq9]

Water Contaminant Testing Market: Growth Trends and Opportunities Through 2024-2033

The PFAS Testing Market is expanding as concerns over water contamination from per- and polyfluoroalkyl substances (PFAS) rise. With stricter environmental regulations and increasing awareness, testing for PFAS in water and soil has become critical.

The Water Contaminant Testing Market is crucial in supporting PFAS testing efforts, with advanced testing kits and analytical tools providing accurate results. The PFAS testing market is valued $335.9 million in 2023, and it is expected to grow at a CAGR of 9.33% and reach $893.2 million by 2034

Market Growth

The Water Contaminant Testing Market is experiencing significant growth due to increasing concerns about water contamination and stricter environmental regulations globally. Governments and regulatory bodies are enforcing mandatory testing for industries that may discharge harmful contaminants into water sources, boosting demand for advanced testing solutions. Public awareness of the health risks associated with various waterborne contaminants, including PFAS, has further driven the need for regular testing of water and soil.

Request a free sample report of the PFAS Testing Market

Key Technologies

Advanced Testing Kits

Advanced testing kits in the Water Contaminant Testing Market are designed to detect even trace amounts of PFAS in water, ensuring compliance with safety standards. These kits offer rapid, reliable results, allowing for proactive measures to mitigate contamination and protect public health.

High-Sensitivity Analytical Tools

High-sensitivity analytical tools provide precise measurements of PFAS contamination in water and soil samples. These tools, such as mass spectrometry and chromatography, enable accurate detection at very low concentrations, ensuring environmental safety and compliance with strict regulations in the Water Contaminant Testing Market.

Demand Drivers

Rising Environmental Concerns: Increasing global awareness of water contamination is driving demand for PFAS testing.

Government Regulations: Stricter environmental laws are fueling the need for comprehensive testing solutions.

Download Complete TOC of the PFAS Testing Market

Advanced Techniques in the Water Contaminant Testing Market

The Water Contaminant Testing Market is segmented by technique into various advanced methods, including Liquid Chromatography with Tandem Mass Spectrometry (LS-MS-MS), which is widely used for its accuracy in detecting PFAS. Gas Chromatography-Mass Spectrometry (GC-MS) is another key method for identifying volatile contaminants. Nuclear Magnetic Resonance Spectroscopy provides molecular-level insights, while Combustion Ion Chromatography is used for detecting anions. The Enzyme-Linked Immunosorbent Assay (ELISA) is a popular biochemical technique for detecting specific contaminants, and Mass Spectrometry is valued for its high sensitivity in trace detection. Other methods encompass specialized, or hybrid techniques tailored for various contaminant detection needs.

Some of the prominent names in this market are:

•    Agilent Technologies, Inc. •    Merck KGaA •    Waters Corporation •    Biotage •    AccuStandard •    PerkinElmer Inc. •    Thermo Fisher Scientific Inc. •    Phenomenex, Inc. •    Shimadzu Corporation •    Restek Corporation •    Avantor, Inc. •    Intertek Group plc •    SCIEX •    ALS Laboratories (UK) Ltd •    SGS Société Générale de Surveillance SA.

Conclusion

As water safety concerns rise, the Water Contaminant Testing Market will be pivotal in ensuring environmental compliance and safeguarding public health. With advanced testing technologies and stricter regulations, this market will continue to grow, providing essential tools for detecting harmful contaminants and promoting water safety worldwide.

Get more market insights on Advanced materials chemicals

BIS Research, recognized as a best market research company, provides premium market intelligence reports on deep technologies poised to cause significant market disruption in the coming years.

At BIS Research, we focus exclusively on technologies related to precision medicine, medical devices, diagnostics, life sciences, artificial intelligence (AI), machine learning (ML), Internet of Things (IoT), big data analysis, blockchain technology, 3D printing, advanced materials and chemicals, agriculture and FoodTech, mobility, robotics and UAVs, and aerospace and defense, among others

[mordorintelligencemarketresearch]

Rapid Microbiology Testing Industry: Revolutionizing Diagnostics

Market Overview

The Rapid Microbiology Testing Market is projected to grow from USD 5.51 billion in 2024 to USD 8.68 billion by 2029, registering a compound annual growth rate (CAGR) of 9.53% during the forecast period (2024-2029).

The Rapid Microbiology Testing Industry is rapidly gaining momentum as an essential part of the global healthcare and pharmaceutical sectors. The ability to detect microbial contamination and infections in real-time is revolutionizing diagnostic processes, reducing turnaround times, and improving patient outcomes. The industry has seen consistent growth, driven by increasing demand for rapid diagnostic solutions in clinical, industrial, and environmental applications.

Market Growth and Drivers

According to market research, the global rapid microbiology testing market is projected to experience strong growth, with a compound annual growth rate (CAGR) of over 9-10% during the forecast period. The increasing prevalence of infectious diseases, including the COVID-19 pandemic, has accelerated the demand for rapid, accurate diagnostic tools. The healthcare sector, in particular, benefits from rapid microbiology testing, as it enables quicker identification of pathogens, aiding in timely treatment decisions.

Key Technologies in Rapid Microbiology Testing

The industry is evolving with the introduction of cutting-edge technologies, such as:

PCR (Polymerase Chain Reaction): Widely used for detecting pathogens with high sensitivity and specificity.

Mass Spectrometry: Offers high-throughput capabilities and is gaining popularity for microbial identification.

Biosensors: Provide on-site, real-time detection, making them invaluable for both clinical diagnostics and environmental monitoring.

Automated Systems: Increasingly adopted in clinical labs and industries for their speed, accuracy, and ability to handle high volumes of tests.

Applications in Various Sectors

Clinical Diagnostics: Rapid microbiology testing plays a pivotal role in hospitals and clinics, aiding in the early diagnosis of infections such as sepsis, respiratory diseases, and UTIs. With the growing threat of antimicrobial resistance (AMR), these tests are also crucial for appropriate antibiotic stewardship.

Pharmaceutical & Biotechnology: The industry relies on rapid microbial detection methods to ensure the safety and sterility of drugs, vaccines, and biological products, aligning with stringent regulatory requirements.

Food & Beverage Industry: Rapid microbiology testing is critical in preventing foodborne illnesses by ensuring that production lines are free from microbial contamination.

Environmental Monitoring: As environmental concerns grow, industries are turning to rapid microbiology tools to monitor water, air, and soil for microbial pollutants.

Challenges and Opportunities

While the rapid microbiology testing market shows robust growth potential, it faces challenges related to the high cost of advanced testing technologies and the need for skilled personnel to operate these systems. However, the industry is witnessing increasing investments in research and development, which will likely reduce costs and improve accessibility. Furthermore, the trend toward automation and miniaturization is expected to drive adoption across smaller healthcare facilities and resource-limited settings.

Future Outlook

With continued advancements in technology and a growing emphasis on faster diagnostic solutions, the rapid microbiology testing market is set to transform how industries and healthcare systems approach microbial detection. As demand rises, particularly in the wake of pandemics and increased global health concerns, rapid microbiology testing will play an increasingly vital role in public health, safety, and environmental sustainability.

In conclusion, the rapid microbiology testing industry is evolving as a cornerstone of modern diagnostics. With its vast range of applications and the ongoing development of faster, more accurate, and cost-effective solutions, it is poised for sustained growth in the years to come.

For a detailed overview and more insights, you can refer to the full market research report by Mordor Intelligence

[shubhampawrainfinium]

A New Dimension of Biology: The Rise of Single Cell Multiomics

The global single cell multiomics market is experiencing significant growth, driven by advancements in biotechnology and the rising demand for precision medicine. According to the report, the market is projected to grow at a compound annual growth rate (CAGR) of approximately 18% during the forecast period of 2022-2028. In 2022, the global single cell multiomics market was valued at around USD 3.5 billion, and it is expected to reach nearly USD 9.5 billion by 2028.

What is Single Cell Multiomics?

Single cell multiomics is an advanced analytical approach that studies individual cells by combining multiple 'omics' platforms, such as genomics, transcriptomics, proteomics, and epigenomics. This method provides a comprehensive understanding of the cellular functions and the underlying molecular mechanisms. By analyzing a single cell's DNA, RNA, proteins, and epigenetic markers, researchers can uncover unique insights into cellular heterogeneity and disease mechanisms that are not possible with bulk cell analysis.

Get Sample pages of Report: https://www.infiniumglobalresearch.com/reports/sample-request/35323

Market Dynamics and Growth Drivers

Several factors are contributing to the rapid growth of the global single cell multiomics market:

Rising Demand for Precision Medicine: Precision medicine aims to tailor medical treatments to individual patients based on their genetic and molecular profile. Single cell multiomics plays a pivotal role in this approach by providing detailed insights into individual cells, enabling better understanding and treatment of complex diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.

Technological Advancements: Advances in next-generation sequencing (NGS), mass spectrometry, and bioinformatics have made it easier and more cost-effective to conduct single cell multiomics studies. These innovations are driving adoption across academic and clinical research settings, allowing for more comprehensive analysis of cellular functions.

Growing Focus on Cancer Research: Cancer research is one of the primary applications of single cell multiomics, as it helps to decipher tumor heterogeneity, drug resistance, and tumor microenvironments at the single-cell level. The growing prevalence of cancer globally is fueling the demand for single cell multiomics in oncology research.

Increased Government and Private Funding: Governments and private organizations are investing heavily in genomics and precision medicine initiatives, providing funding and grants to support research in single cell analysis. These efforts are expected to boost market growth during the forecast period.

Regional Analysis

North America: North America holds the largest share of the global single cell multiomics market, primarily driven by the region’s advanced healthcare infrastructure, significant investment in precision medicine, and the presence of key market players. The United States, in particular, is a hub for genomics research, with major academic and research institutions adopting single cell technologies.

Europe: Europe is another prominent market for single cell multiomics, with countries like the U.K., Germany, and France at the forefront of multiomics research. The region’s robust research landscape, coupled with government initiatives supporting genomics research, is contributing to market growth.

Asia-Pacific: The Asia-Pacific region is expected to witness the fastest growth during the forecast period, driven by increasing investments in biotechnology and healthcare research in countries like China, Japan, and India. Growing awareness about precision medicine and improving healthcare infrastructure are also key factors driving market expansion in this region.

Rest of the World: While the adoption of single cell multiomics is still in its early stages in regions like Latin America and the Middle East & Africa, growing interest in genomics and personalized medicine is expected to create future growth opportunities.

Competitive Landscape

The global single cell multiomics market is highly competitive, with several key players actively contributing to advancements in the field. Major companies include:

10x Genomics: A leader in single cell sequencing technologies, offering solutions that enable comprehensive single cell multiomics analysis for research and clinical applications.

Illumina, Inc.: A major player in the genomics space, providing sequencing platforms and technologies that support single cell analysis and multiomics studies.

Fluidigm Corporation: Specializes in developing single cell proteomics and genomics platforms, helping researchers investigate cellular heterogeneity and molecular interactions.

Becton, Dickinson and Company (BD): Offers innovative solutions for single cell multiomics, including platforms for high-dimensional proteomics and transcriptomics.

QIAGEN: Known for its sample preparation and bioinformatics solutions, QIAGEN supports multiomics research by enabling comprehensive data analysis and integration.

Report Overview : https://www.infiniumglobalresearch.com/reports/global-single-cell-multiomics-market

Challenges and Opportunities

Despite its promising growth, the single cell multiomics market faces several challenges. High costs associated with single cell technologies and data analysis, as well as the complexity of multiomics data interpretation, may hinder widespread adoption, particularly in resource-constrained regions. Additionally, the integration of multiple 'omics' datasets and the lack of standardized protocols pose technical challenges.

However, there are substantial opportunities for growth. Continuous advancements in technology, decreasing costs of sequencing, and the growing adoption of artificial intelligence (AI) and machine learning (ML) for data analysis are expected to drive market expansion. Furthermore, as researchers uncover more insights into cellular heterogeneity, new applications of single cell multiomics in disease research, drug development, and personalized medicine are likely to emerge.

Conclusion

The global single cell multiomics market is poised for robust growth, with a projected CAGR of nearly 18% from 2022 to 2028. This market's expansion is fueled by increasing demand for precision medicine, advancements in biotechnology, and growing research applications in cancer and drug development. As the field of single cell multiomics continues to evolve, it holds the potential to revolutionize healthcare by enabling more accurate diagnostics, personalized treatments, and a deeper understanding of complex diseases.

[insightfulblogz]

High-Performance Liquid Chromatography Market Growth Statistics and Key Players Insights (2024-2032)

High-Performance Liquid Chromatography (HPLC) is a powerful analytical technique used to separate, identify, and quantify components in complex mixtures. Widely employed in pharmaceutical, environmental, food, and chemical industries, HPLC has become a cornerstone of analytical chemistry due to its precision, accuracy, and versatility. This technique works by passing a liquid sample through a column filled with a solid adsorbent material, allowing different components to interact with the stationary phase and separate based on their unique properties. HPLC is essential for ensuring product quality, safety, and efficacy across multiple industries.

The High-Performance Liquid Chromatography Market size was valued at USD 4.8 billion in 2023 and is expected to grow to USD 7.83 billion by 2031 and grow at a CAGR of 6.30% over the forecast period of 2024-2031.

Future Scope

The future of HPLC is set to evolve with ongoing advancements in instrument technology and data analysis software. Miniaturization of HPLC systems, allowing for more portable and user-friendly devices, is expected to broaden the scope of applications. Additionally, the integration of HPLC with mass spectrometry (LC-MS) will continue to enhance the sensitivity and resolution of analytical results. Research is also focusing on the development of eco-friendly HPLC techniques, such as using green solvents and reducing waste generation. As industries demand faster, more accurate analyses, HPLC technology will play an increasingly vital role in research and quality control.

Trends

Several trends are shaping the HPLC market. One key trend is the increasing adoption of ultra-high-performance liquid chromatography (UHPLC), which offers faster separation times and higher resolution compared to traditional HPLC. Another trend is the rising demand for bioanalytical applications, particularly in drug discovery and clinical research, where HPLC is used to analyze biological samples and assess pharmacokinetics. Additionally, the development of automation and robotics in HPLC systems is driving efficiency and throughput in laboratory settings. Green HPLC, with a focus on reducing environmental impact, is also gaining traction as sustainability becomes a priority in scientific research.

Applications

HPLC is widely used in the pharmaceutical industry for drug development, quality control, and purity testing. In the food and beverage industry, it is applied to detect contaminants, verify ingredient authenticity, and monitor product quality. HPLC is also crucial in environmental analysis for detecting pollutants in water, air, and soil. Additionally, it plays a vital role in clinical laboratories, where it is used for diagnosing diseases, monitoring therapeutic drug levels, and performing forensic analyses.

Get Sample Copy of the Report: https://www.snsinsider.com/sample-request/3083 

Key Points

High-Performance Liquid Chromatography (HPLC) is a key analytical tool for separating and identifying components in mixtures.

It is widely used in pharmaceuticals, food safety, environmental testing, and clinical diagnostics.

Trends include the rise of UHPLC, bioanalytical applications, automation, and green HPLC techniques.

HPLC is essential for ensuring product quality, safety, and environmental compliance.

Future developments focus on miniaturization, eco-friendly techniques, and integrated systems like LC-MS.

Conclusion

High-Performance Liquid Chromatography continues to be an indispensable tool in scientific research and industry. With ongoing technological advancements and the integration of automation, HPLC will further enhance the precision, speed, and reliability of analytical processes. As sustainability becomes increasingly important, the development of green HPLC techniques will ensure that this technology remains at the forefront of innovation in analytical chemistry. Through continuous improvements, HPLC is set to play a crucial role in driving progress across multiple fields, from pharmaceuticals to environmental science.

[trendingreportz]

Single-cell Genome Sequencing Market - Forecast(2024 - 2030)

Single-cell Genome Sequencing Market Overview 

The Single-cell Genome Sequencing size is estimated to reach $9 billion by 2030, growing at a CAGR of 16.2% during the forecast period 2023-2030. Single-cell genome sequencing is one of the major areas of research for finding a cure for chronic ailments such as cancer. The rising cases of cancer worldwide would drive the Single-cell Genome Sequencing Market during the forecast period. According to Cancer.org, the global burden of new cancer cases would grow to 27.5 million by 2040. This would certainly boost the demand for Single-cell Genome Sequencing Market to find a cure for such chronic diseases.

Rapid development in sequencing technologies is also expected to drive the growth of this market during the forecast period. Polymerase chain reaction (PCR) and next-generation sequencing are emerging as the preferred technologies for various applications, especially for single-cell genomic sequencing. In January 2022, a group of medical Scientists at Stanford and their collaborators developed a new ultra-fast genome sequencing approach that offered a diagnostic rate of about 12% higher than the average rate for diagnosing mystery illnesses.

Request Sample

Single-cell Genome Sequencing Market - Report Coverage:

The “Single-cell Genome Sequencing Market Report- Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Single-cell Genome Sequencing Market.AttributeSegment

By Product Type

Consumables

Reagents

By Technique

Flow Cytometry

Next-generation Sequencing

Polymerase Chain Reaction

Microscopy

Mass Spectrometry

Others

By Application

Cancer

Immunology

Microbiology

Others

By End-User

Academic and Research Laboratories

Hospitals and Diagnostic Centers

Biotechnology and Pharmaceutical Companies

Cell Banks and IVF Centers

By Geography

North America (the U.S., Canada and Mexico)

Europe (Germany, France, the UK, Italy, Spain, Russia and the Rest of Europe),

Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and the Rest of Asia-Pacific),

South America (Brazil, Argentina, Chile, Colombia and the Rest of South America)

The Rest of the World (the Middle East and Africa).

COVID-19 / Ukraine Crisis - Impact Analysis: 

The COVID-19 pandemic had a positive impact on the Single-cell Genome Sequencing Market. The studies on single-cell genome sequencing offered critical insights into coronavirus infection and allowed medical experts better understand the nature of the infection. On performing single-cell sequencing, most cell types in patients with COVID-19 showed a significant interferon-α response along with an overall acute inflammatory response.

 Russia’s invasion of Ukraine has made a significant impact on the Single-cell Genome Sequencing market. It has not only affected the lives and work of genomic researchers in these countries but has also influenced the relationships with colleagues in the U.S. and elsewhere.

The sanctions against Russia are most likely to bring experimental genomics research in the country to a halt. Ukraine had several genomics research projects going on before the war began. Now, with all the unrest, most researchers in Ukraine are fleeing the country and looking for positions in the west.

Inquiry Before Buying

Key Takeaways: 

Fastest Growth in the Asia-Pacific Region : Geographically, in the global Single-cell Genome Sequencing market share, Asia-Pacific is analyzed to grow with the highest CAGR of 17.2% during the forecast period 2023-2030. This growth is driven by the rising number of cancer cases in the region. According to the projections by the International Agency for Research on Cancer, there would be about 15.1 million new cases per year in Asia until 2040. The unprecedented rate of population aging is the key determinant of this development. Japan, the country with the oldest population in the world, also has the highest rate of cancer. This would drive growth in the Single-cell Genome Sequencing Market in the region during the forecast period.

Reagents Segment to Register the Fastest Growth : In the Single-cell Genome Sequencing analysis, the Reagents segment is estimated to grow with the highest CAGR of 17% during the forecast period. This is because the use of single-cell sequencing reagents allows the experts to process bulk samples with the input of as few as 100 cells. With the recent advancements in single-cell DNA sequencing techniques, bulk DNA sequencing can be done more efficiently and cost-effectively. Moreover, commercial reagents are now available for all the wet-lab steps of a scRNA-seq protocol as well as for preparing barcoded cDNA libraries. The increasing availability of reagents and their growing need in various single-cell genome sequencing processes are boosting its growth in the Single-cell Genome Sequencing Market during the forecast period.

Academic and Research Laboratories Segment is Leading the Market : According to the Single-Cell Genome Sequencing Market forecast, the academic and research laboratories segment held the largest market share of 38.6% in 2022. Single-cell genomics is emerging as one of the major areas in scientific research and development. The rising prevalence of chronic diseases demands new cures and treatment options, which is further boosting the growth of the academic and research laboratories segment. Moreover, understanding the genomics of individual cells opens up a new set of opportunities for the world of biotechnology.

Increased Funding for Vaccine Development and Production : Government agencies in various parts of the world have increased funding for the development and production of vaccines in response to the pandemic. This has led to increased use of single-cell analysis (SCA) tools for COVID-19 research. SCA helps in the assessment of the peripheral immune function of the disease and contributes to the study of the pathophysiology and treatment possibilities of the disease. Thus, the market is positively impacted by COVID-19.

Massive Demand in the field of Immunology, Oncology and Others : Single-cell technology is used in the molecular-level examination of processes and pathways of cellular heterogeneity along with its assessment. This rapidly developing technology has major applications in immunology, oncology and other major areas. Moreover, the development of advanced tools that help make proteomic and transcriptomic processes simpler is also driving the use of single-cell analysis methods, boosting the growth of the Single-cell Genome Sequencing Market.

High Cost of Instruments to Hinder Market Growth : While there is a significant demand for genome sequencing machines among the end-user industries, the instrument costs are significantly high. According to a report published in Bloomberg, Illumina’s new NovaSeq X series costs $985,000 for the base machine and $1.25 million for the advanced one. Such high cost of instruments are likely to hinder the growth of the Single-cell Genome Sequencing Market.

Schedule a Call

Key Market Players:

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Single-Cell Genome Sequencing Market.

The top 10 companies in this industry are listed below:

Standard BioTools Inc. (Maxpar®, Advanta™ Assays)

QIAGEN N.V. (QIAseq FX, REPLI-g)

Illumina, Inc. (NovaSeq, NextSeq)

F. Hoffmann-La Roche AG (AVENIO, MagNA Pure)

Thermo Fisher Scientific, Inc. (Invitrogen, Applied Biosystems)

Bio-Rad Laboratories, Inc. (SEQuoia, ddSEQ)

10X Genomics, Inc. (Chromium, Visium)

Becton, Dickinson and Company (BD Rhapsody™, BD AbSeq)

Oxford Nanopore Technologies Limited (MinION, GridION)

Beijing Genomics Institute Group (CardioGen, COLOTECT™)

 Buy Now

Scope of the Report:

Report MetricDetails

Base Year Considered

2022

Forecast Period

2023–2030

CAGR

16.2%

Market Size in 2030

$9 billion

Segments Covered

Product Type, Technique, Application, End-user and Region

Geographies Covered

North America (the U.S., Canada and Mexico) Europe (Germany, France, the UK, Italy, Spain, Russia and the Rest of Europe),Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand and the Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and the Rest of the World (the Middle East and Africa).

Key Market Players

Standard BioTools Inc.

QIAGEN N.V.

Illumina, Inc.

F. Hoffmann-La Roche AG

Thermo Fisher Scientific, Inc.

Bio-Rad Laboratories, Inc.

10X Genomics, Inc.

Becton, Dickinson and Company

Oxford Nanopore Technologies Limited

Beijing Genomics Institute Group

Pacific Biosciences of California, Inc.

NuGEN Technologies, Inc.

Novogene Co. Ltd.

Takara Bio, Inc.

Danaher Corporation

[industrynewsupdates]

Role of Technology in the Newborn Screening Market

The global newborn screening market was valued at USD 789.35 million in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 7.54% from 2023 to 2030. This growth is primarily driven by several factors, including an increasing neonatal population, a rising incidence of congenital diseases in newborns, heightened consumer awareness, and supportive initiatives from various governments that are implementing programs and legislations to promote newborn screening. Additionally, advancements in screening technologies are expected to further enhance market growth.

The growing prevalence of congenital diseases among newborns is anticipated to positively impact the newborn screening market. According to data released by the World Health Organization (WHO) in February 2023, approximately 240,000 newborns worldwide die within the first 28 days of life each year due to congenital conditions. These disorders are also linked to around 170,000 child deaths annually among those aged between one month and five years. Furthermore, research from Indian Pediatrics indicates that congenital hypothyroidism occurs in 2.1 out of every 1,000 infants in India, with the prevalence of inborn metabolic disorders ranging from 2% to 7.8%. The significant occurrence of congenital diseases in newborns is likely to drive the demand for testing, thereby accelerating market growth by 2030.

Gather more insights about the market drivers, restrains and growth of the Newborn Screening Market

Technology Insights

In 2022, the tandem mass spectrometry segment emerged as the dominant force in the newborn screening market, capturing 24.5% of the overall revenue share. This leadership position can be attributed to several key factors, including its cost-effectiveness, broader applicability across various testing scenarios, and continuous technological advancements. Tandem mass spectrometry (MS/MS) is particularly valued for its ability to efficiently diagnose a wide range of medical conditions in a single testing procedure, making it an invaluable tool in newborn screening.

The efficiency of tandem mass spectrometry allows healthcare professionals to conduct comprehensive screenings that can identify multiple disorders simultaneously, thereby facilitating timely interventions. As the healthcare landscape evolves, the demand for rapid and accurate diagnostic tools has surged. This trend is likely to propel the tandem mass spectrometry segment to experience substantial growth, with a significant compound annual growth rate (CAGR) projected over the coming years. The innovative advancements being made by key market players are also expected to contribute to this growth. For example, in April 2023, Waters Corporation unveiled its new Xevo TQ Absolute IVD Mass Spectrometer, designed specifically for clinical applications. This product exemplifies the continuous push for technological enhancements that not only improve diagnostic accuracy but also streamline laboratory workflows.

In addition to tandem mass spectrometry, the electrophoresis segment is anticipated to see notable demand, projecting an impressive CAGR of 8.09% throughout the forecast period. The increasing emphasis on early detection techniques in healthcare is a primary driver behind this growth. Early diagnosis is crucial in managing congenital diseases effectively, as it allows for timely treatment and better health outcomes for newborns. Consequently, as healthcare providers and institutions prioritize early intervention strategies, the demand for electrophoresis is expected to rise correspondingly.

The growth of the electrophoresis segment is further supported by a surge in collaborations among various market players. Such partnerships often lead to innovative solutions that enhance product offerings and broaden market reach. For instance, in October 2022, CMP Scientific Corp. entered into a co-marketing agreement with Agilent to promote its advanced electrophoresis system. This collaboration not only aims to improve the technological capabilities of electrophoresis solutions but also focuses on expanding accessibility to these crucial diagnostic tools in newborn screening programs.

Moreover, the increasing focus on research and development in the field of newborn screening technologies is set to further enhance the capabilities of both tandem mass spectrometry and electrophoresis. As new methodologies and products are introduced, healthcare providers will be better equipped to address the complexities associated with congenital diseases. The integration of advanced technologies is expected to foster innovation, leading to more efficient, reliable, and cost-effective solutions for newborn screening.

Order a free sample PDF of the Newborn Screening Market Intelligence Study, published by Grand View Research.